Behind the headlines - Autumn 2022
14 November 2022
Autumn 2022
Eye health issues that are making the news - Autumn 2022.
Caffeine metabolite may slow child myopia progression in children
Short-sightedness was observed to progress more slowly in children taking a compound derived from coffee, according to a new study.
Researchers found that taking 7-methylxanthine (7-MX) – a caffeine metabolite licensed as a myopia treatment in Denmark since 2009 – was associated with smaller increases in axial elongation and refractive error.
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
Should we be attempting to control myopia progression in a clinical setting? And,if so, what are the options?
This narrative review summarises emerging interventions that may be mentioned in the popular and professional press, and may be on our menu of treatment options to discuss with patients in the near future.
The College of Optometrists has published a report reflecting on the history and impact of its research work and funding.